WhiteSwell, a Galway medtech firm that raised $78 million (€68.2 million) from investors, has collapsed after its latest round of funding fell through. A provisional liquidator, Aengus Burns of Burns Advisory, has been appointed to wind up the business with a full hearing to take place at the end of this month. WhiteSwell was led by Eamon Brady who previously led two medtech firms that were acquired by Johnson & Johnson and Abbott. The company, founded in 2014, was developing a device for treating heart failure and had completed some clinical trials into the device, with results of its latest…

Want to continue reading?

Join today with an Annual membership and unlock full access to The Currency and The Wall Street Journal for just €200 – two premium memberships, one subscription.

Subscribe

Cancel at any time.

Are you already a member? .